✦ LIBER ✦

The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial

✍ Scribed by Maximilian Burger; Nicolas Thiounn; Stefan Denzinger; Jozsef Kondas; Gerard Benoit; Manuel S Chapado; Fernando J Jimenz-Cruz; Laszlo Kisbenedek; Zoltán Szabo; Domján Zsolt; Marc O Grimm; Imre Romics; Joachim W Thüroff; Tamas Kiss; Bertrand Tombal; Manfred Wirth; Marc Munsell; Bonnie Mills; Tung Koh; Jeff Sherman

Book ID: 119905626
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 536 KB
Volume: 8
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-8-54

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

657 ADJUVANT AUTOLOGOUS INTRAVESICAL MAC

657 ADJUVANT AUTOLOGOUS INTRAVESICAL MACROPHAGE CELL THERAPY VS. BCG FOR NON-MUSCLE INVASIVE BLADDER CANCER: A PHASE II, MULTICENTER, RANDOMIZED TRIAL

✍ M. Burger; N. Thiounn; N. Denzinger; B. Malavaud; M. Wirth; J.W. Thüroff; I. Rom 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 506 KB

1064 A NOVEL SIMULATION MODEL OF NON-MUS

1064 A NOVEL SIMULATION MODEL OF NON-MUSCLE INVASIVE BLADDER CANCER A PLATFORM FOR A VIRTUAL RANDOMIZED TRIAL OF CONSERVATIVE THERAPY VS CYSTECTOMY IN BCG REFRACTORY PATIENTS

✍ Dinh, Tuan A.; Noah-Vanhoucke, Joyce; Rengarajan, Badri; Mayo, Kevin W.; Goswami 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 113 KB

776 An economic analysis of the TAX 326

776 An economic analysis of the TAX 326 trial: a multicenter randomized study of docetaxel + cisplatin (DC) or docetaxel + carboplatin (DCb) vs. vinorelbine + cisplatin (VC) as first-line therapy in advanced non-small cell lung cancer (NSCLC)

✍ N. Leighl; F.A. Shepherd; W.S. Tsao; P. Lindgren; C.B. Belani; F.V. Fossella; P. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 336 KB